Characterization of patients with anti-modified citrullinated vimentin antibodies (MCVA)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Characterization of patients with anti-modified citrullinated vimentin antibodies (MCVA) ; volume:9 ; number:2 ; day:23 ; month:11 ; year:2011 ; pages:1 ; date:12.2011
Journal of translational medicine ; 9, Heft 2 (23.11.2011), 1, 12.2011
- Urheber
-
Ruiz-Ortiz de Arrizabaleta, Estíbaliz
- Beteiligte Personen und Organisationen
-
Grados-Cánovas, Dolors
Teniente-Serra, Aina
Salvador-Corres, Iñaki
Marin, Ana
Martínez-Morillo, Melania
Holgado, Susana
Olivé, Alejandro
Pujol-Borrell, Ricardo
Martínez-Cáceres, Eva
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-9-S2-P52
- URN
-
urn:nbn:de:1111-2016041439240
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ruiz-Ortiz de Arrizabaleta, Estíbaliz
- Grados-Cánovas, Dolors
- Teniente-Serra, Aina
- Salvador-Corres, Iñaki
- Marin, Ana
- Martínez-Morillo, Melania
- Holgado, Susana
- Olivé, Alejandro
- Pujol-Borrell, Ricardo
- Martínez-Cáceres, Eva
- SpringerLink (Online service)
Ähnliche Objekte (12)
Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin
Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis
Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis
Assessment of serum antimutated citrullinated vimentin antibodies in rheumatoid arthritis
Erratum: Assessment of serum antimutated citrullinated vimentin antibodies in rheumatoid arthritis
Diagnostic value and clinical significance of antibodies against a modified citrullinated vimentin (anti-MCV) in patients with early juvenile arthritis
The value of antibodies against mutated citrullinated vimentin in juvenile idiopathic arthritis
Anti-modified citrullinated vimentin antibody: a novel biomarker associated with cardiac systolic dysfunction in patients with rheumatoid arthritis
Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy
Citrullinated vimentin as an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteins
Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort study
Different Clinical Relevance of Anti-Citrullinated Protein Antibodies in RA Patients
Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin
Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis
Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis
Assessment of serum antimutated citrullinated vimentin antibodies in rheumatoid arthritis
Erratum: Assessment of serum antimutated citrullinated vimentin antibodies in rheumatoid arthritis
Diagnostic value and clinical significance of antibodies against a modified citrullinated vimentin (anti-MCV) in patients with early juvenile arthritis
The value of antibodies against mutated citrullinated vimentin in juvenile idiopathic arthritis
Anti-modified citrullinated vimentin antibody: a novel biomarker associated with cardiac systolic dysfunction in patients with rheumatoid arthritis
Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy
Citrullinated vimentin as an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteins
Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort study
Different Clinical Relevance of Anti-Citrullinated Protein Antibodies in RA Patients
Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin
Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis
Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis
Assessment of serum antimutated citrullinated vimentin antibodies in rheumatoid arthritis
Erratum: Assessment of serum antimutated citrullinated vimentin antibodies in rheumatoid arthritis
Diagnostic value and clinical significance of antibodies against a modified citrullinated vimentin (anti-MCV) in patients with early juvenile arthritis
The value of antibodies against mutated citrullinated vimentin in juvenile idiopathic arthritis
Anti-modified citrullinated vimentin antibody: a novel biomarker associated with cardiac systolic dysfunction in patients with rheumatoid arthritis
Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy
Citrullinated vimentin as an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteins
Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort study